0
Onconova Therapeutics, Inc. has reached its limit for free report views
Work for Onconova Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.
Onconova Therapeutics, Inc.
- 11-50 Employees
- Based in Newtown, Pennsylvania
Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's lead candidate, is a proprietary Phase 3 small molecule agent, which the Company believes blocks cellular signaling by targeting RAS effector pathways.
Onconova Therapeutics, Inc.
Most Recent Annual Report
MOST RECENT
2019 Annual Report and Form 10K
Report Locked. Onconova Therapeutics, Inc. has reached its limit for free report views.
